INBIOGEN CO.,Ltd Logo

INBIOGEN CO.,Ltd

A life sciences firm offering bioinformatics and data mining services to biotech firms.

101140 | KO

Overview

Corporate Details

ISIN(s):
KR7101140002
LEI:
Country:
South Korea
Address:
서울특별시 강남구 언주로135길 21 2층(논현동), 강남구

Description

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-24 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-12-24 00:00
주주총회소집결의
Korean HTML 6.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 749.8 KB
2025-07-28 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 85.5 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean HTML 831.3 KB
2025-03-31 00:00
정기주주총회결과
Korean HTML 24.4 KB
2025-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean HTML 10.0 KB
2025-03-21 00:00
감사보고서제출
Korean HTML 12.4 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean HTML 395.1 KB
2025-03-14 00:00
[기재정정]주주총회소집결의
Korean HTML 19.5 KB
2025-03-14 00:00
[기재정정]주주총회소집공고
Korean HTML 148.6 KB
2025-03-13 00:00
주주총회소집공고
Korean HTML 115.1 KB
2025-03-12 00:00
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean HTML 20.0 KB
2025-03-12 00:00
주주총회소집결의
Korean HTML 12.3 KB
2025-01-22 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean HTML 11.6 KB

Automate Your Workflow. Get a real-time feed of all INBIOGEN CO.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INBIOGEN CO.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INBIOGEN CO.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Circio Holding ASA Logo
Clinical-stage company developing circular RNA medicines and immunotherapies.
Norway
CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
Compugen Ltd. Logo
A clinical-stage company developing cancer immunotherapies using an AI platform.
Israel
CGEN
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.